What if the real reason you get stuck isn’t lack of discipline, or motivation, but an unconscious pattern?

In this talk, you’ll learn why you get stuck & how to tap into the hidden patterns driving your decisions, results, and relationships. And how to shift into an empowering pattern that fuels clarity, confidence, and aligned action.

When you shift the unconscious, you don’t just change your thoughts, you change your life.

By transforming the hidden patterns behind trauma, anxiety, excess weight, and limiting beliefs, he helps clients unlock clarity, confidence, peak performance, and long lasting change.

Matan helps people rewire unconscious beliefs so they break through trauma, anxiety, and self-sabotage. Creator of a results-driven methodology that builds clarity, confidence, & freedom with aligned action.

Many people with amyloidosis spend years seeing doctors, running tests, and being told “everything looks normal.” This session explains why amyloidosis is so hard to diagnose, the red flags that are often overlooked, and what patients and caregivers can do to advocate for the right tests and the right specialists; so answers come sooner, not later.

Dr. Morie Gertz is Roland Seidler Jr. Professor of the Art of Medicine and Chair Emeritus of Internal Medicine at Mayo Clinic Rochester. A world-renowned expert in amyloidosis and plasma cell disorders, he has led clinical research and trials in AL amyloidosis and served in key roles in the International Society of Amyloidosis. He has authored 800+ peer-reviewed publications and received multiple major awards.

This half-day session is designed specifically for people who have been newly diagnosed with ATTR amyloidosis. It is not a medical decision-making session and is not intended for AL or other forms of amyloidosis.

The goal is to help ATTR patients understand what is happening, learn the basic language of the disease, and begin to process what “a new normal” looks like. Topics include ATTR basics, how ATTR differs from AL, treatment categories, care team communication, and practical next steps. The session combines short presentations with guided discussion so patients can learn, ask questions, and hear from others on a similar path.

Stacey Goodman, MD completed her hematology training at the NIH and Vanderbilt University before joining the faculty in 1993. She helped create and lead the Vanderbilt Amyloidosis Multidisciplinary Program (VAMP) until her retirement in 2021. She currently serves as a member of the board of directors at the Amyloidosis Foundation.

Managing heart failure medications can be confusing. This session explains how different drugs work together, why dosing and timing matter, and how to monitor results. With proper medication management, your doctor can address symptoms like fatigue that may be caused by medications, the disease itself, or both, helping optimize care and daily functioning.

Daniel Lenihan, MD, is a cardio-oncologist who specializes in cardiology, heart disease and advanced heart failure/cardiac transplant. His areas of interest include cardiotoxicity of cancer therapy, early phase clinical trials, amyloidosis, cardiomyopathy and cancer survivorship.

We have covered many amyloidosis topics across our sessions. This session pulls it all together by separating the signal from the noise and highlighting five essential concepts every amyloidosis patient needs to know. Get a clear, practical overview of the most important ideas that impact care, decisions, and daily life.

David Gusick is the founder of Somebody To Talk To, a program bringing patients, caregivers, and doctors together for free weekly sessions. With 30+ years in systems architecture and entrepreneurship, he is building a global support model to improve quality of life for rare disease patients.